Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.90M | -10.93M | -8.70M | -7.95M | -7.09M |
| Total Depreciation and Amortization | 5.00K | 4.00K | 3.00K | 2.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 980.00K | 753.00K | 481.00K | 246.00K | 185.00K |
| Change in Net Operating Assets | -283.00K | -532.00K | 235.00K | 434.00K | -239.00K |
| Cash from Operations | -12.20M | -10.71M | -7.98M | -7.27M | -7.14M |
| Capital Expenditure | -7.00K | -10.00K | -12.00K | -13.00K | -6.00K |
| Sale of Property, Plant, and Equipment | 3.00K | 3.00K | -- | 9.00K | 9.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -7.00K | -12.00K | -4.00K | 3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.46M | 14.50M | 23.67M | 12.62M | 13.22M |
| Repurchase of Common Stock | -30.00K | -30.00K | -30.00K | -32.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 1.00K | 0.00 |
| Cash from Financing | 14.43M | 14.47M | 23.64M | 12.59M | 13.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.22M | 3.75M | 15.65M | 5.32M | 6.08M |